已收盤 10-24 16:00:00 美东时间
+0.280
+0.22%
今日重点评级关注:富国银行:维持Kyverna Therapeutics"超配"评级,目标价从24美元升至27美元;Chardan Capital:维持Oculis Holding"买入"评级,目标价从33美元升至51美元
10-09 10:51
JP Morgan analyst Brian Ossenbeck maintains Landstar System (NASDAQ:LSTR) with a Neutral and lowers the price target from $147 to $138.
10-09 02:06
今日重点评级关注:Ascendiant Capital:维持Society Pass"买入"评级,目标价从15美元升至18美元;Ascendiant Capital:维持Surgepays"买入"评级,目标价从9美元升至9.5美元
10-06 08:35
今日重点评级关注:Maxim Group:维持Kazia Therapeutics"买入"评级,目标价从15美元升至20美元;Baird:维持Taysha Gene Therapies"跑赢大市"评级,目标价从7美元升至12美元
10-03 14:32
今日重点评级关注:Maxim Group:上调Adial Pharmaceuticals评级至"买入",目标价1.5美元;BTIG:维持Climb Bio"买入"评级,目标价从7美元升至8美元
10-01 20:13
Evercore ISI Group analyst Jonathan Chappell maintains Landstar System (NASDAQ:LSTR) with a In-Line and lowers the price target from $132 to $125.
10-01 01:24
Lodestar Metals (TSXV:LSTR:CA) (OTCQB:SVTNF) announced a non-brokered private placement of up to 6.67M units at C$0.075 per unit, aiming to raise C$500,000. Each unit includes 1 common share and half ...
09-29 20:19
Landstar System ( ($LSTR) ) just unveiled an update. On August 11, 2025, Landst...
08-13 20:20
Lodestar Battery Metals ( ($TSE:LSTR) ) has provided an update. Lodestar Metals...
08-11 20:13
Landstar System (NASDAQ:LSTR) declares $0.40/share quarterly dividend. Forward yield 1.16% Payable Sept. 9; for shareholders of record Aug. 19; ex-div Aug. 19. See LSTR Dividend Scorecard, Yield Chart...
07-30 20:55